Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/25/2018 |
| Start Date: | October 2004 |
| End Date: | October 2004 |
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fed Conditions
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under
fed conditions.
fed conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to exemestane or any comparable or similar
product.
We found this trial at
1
site
Click here to add this to my saved trials
